Cytomedix gets funding support from Maryland Venture Fund

04/5/2013 | BeckersASC.com

Cytomedix has secured a $500,000 investment from the Maryland Venture Fund. The regenerative medicine company is currently working on its AutoloGel System, which uses platelet-rich plasma for wound healing. The company also manufactures the Angel Whole Blood Separation System, which is used in orthopedic and surgical procedures.

View Full Article in:

BeckersASC.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC